athenahealth, Inc. (ATHN) Analysts See $0.46 EPS; 11 Analysts Covering New Relic, Inc. (NEWR)

April 14, 2018 - By Peter Kolinski

New Relic, Inc. (NYSE:NEWR) Logo

Analysts expect athenahealth, Inc. (NASDAQ:ATHN) to report $0.46 EPS on April, 26.They anticipate $0.36 EPS change or 360.00% from last quarter’s $0.1 EPS. ATHN’s profit would be $18.45M giving it 77.28 P/E if the $0.46 EPS is correct. After having $0.93 EPS previously, athenahealth, Inc.’s analysts see -50.54% EPS growth. The stock decreased 1.51% or $2.18 during the last trading session, reaching $142.2. About 111,559 shares traded. athenahealth, Inc. (NASDAQ:ATHN) has risen 26.77% since April 14, 2017 and is uptrending. It has outperformed by 15.22% the S&P500.

Among 16 analysts covering New Relic Inc (NYSE:NEWR), 11 have Buy rating, 0 Sell and 5 Hold. Therefore 69% are positive. New Relic Inc had 46 analyst reports since August 7, 2015 according to SRatingsIntel. As per Tuesday, September 19, the company rating was maintained by KeyBanc Capital Markets. The firm earned “Market Outperform” rating on Wednesday, November 8 by JMP Securities. The firm has “Buy” rating by Cowen & Co given on Wednesday, February 7. Needham initiated New Relic, Inc. (NYSE:NEWR) on Monday, October 23 with “Buy” rating. The rating was maintained by Guggenheim on Wednesday, February 7 with “Buy”. As per Friday, June 24, the company rating was initiated by Cowen & Co. Cowen & Co maintained it with “Buy” rating and $62.0 target in Wednesday, November 29 report. The firm has “Overweight” rating given on Thursday, September 10 by Morgan Stanley. Stephens maintained New Relic, Inc. (NYSE:NEWR) rating on Wednesday, February 7. Stephens has “Buy” rating and $70.0 target. Oppenheimer maintained New Relic, Inc. (NYSE:NEWR) on Friday, March 23 with “Buy” rating. See New Relic, Inc. (NYSE:NEWR) latest ratings:

02/04/2018 Broker: Needham Rating: Buy New Target: $84.0000 Maintain
23/03/2018 Broker: Oppenheimer Rating: Buy New Target: $85.0000 Maintain
19/03/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $70 New Target: $86 Maintain
16/03/2018 Broker: Robert W. Baird Rating: Buy New Target: $85.0 Maintain
23/02/2018 Broker: Wedbush Rating: Outperform New Target: $86 Initiates Coverage On
07/02/2018 Broker: Guggenheim Rating: Buy New Target: $65.0 Maintain
07/02/2018 Broker: Cowen & Co Rating: Buy New Target: $65.0 Maintain
07/02/2018 Broker: BMO Capital Markets Rating: Hold New Target: $71.0 Maintain
07/02/2018 Broker: Stephens Rating: Buy New Target: $70.0 Maintain
06/02/2018 Broker: Robert W. Baird Rating: Buy New Target: $68.0 Maintain

Investors sentiment decreased to 1 in Q4 2017. Its down 0.09, from 1.09 in 2017Q3. It worsened, as 30 investors sold athenahealth, Inc. shares while 70 reduced holdings. 38 funds opened positions while 62 raised stakes. 45.24 million shares or 0.17% more from 45.16 million shares in 2017Q3 were reported. Tiaa Cref Invest Mgmt Ltd Liability Corporation has 128,067 shares. Adirondack Tru has invested 0.03% of its portfolio in athenahealth, Inc. (NASDAQ:ATHN). Ascend Capital Ltd Liability has invested 0.43% in athenahealth, Inc. (NASDAQ:ATHN). Metropolitan Life holds 2,949 shares. Dimensional Fund Advisors Lp, a Texas-based fund reported 218,819 shares. Avalon Global Asset Mgmt Lc accumulated 40,780 shares. Fincl Bank Of Nova Scotia holds 0.02% or 34,000 shares. Clear Harbor Asset Mngmt Limited Co invested in 0.05% or 2,132 shares. First Personal has 26 shares. Barclays Public Limited Company reported 172,332 shares. 183 were reported by Northwestern Mutual Wealth Mgmt. Goldman Sachs Group Inc reported 551,715 shares stake. Tradewinds Cap Mgmt Ltd Liability Co accumulated 300 shares. Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0.08% invested in athenahealth, Inc. (NASDAQ:ATHN) for 66,372 shares. Aperio Group Limited Company reported 0% of its portfolio in athenahealth, Inc. (NASDAQ:ATHN).

Since October 20, 2017, it had 2 insider purchases, and 18 insider sales for $7.11 million activity. 800 shares were sold by Hull Brandon H, worth $104,000 on Friday, October 20. ROBINSON DAVID ERIC also sold $669,698 worth of athenahealth, Inc. (NASDAQ:ATHN) on Tuesday, January 2. 1,153 shares valued at $157,765 were sold by Haley Daniel P on Thursday, March 1. Another trade for 5,000 shares valued at $669,515 was made by Bush Jonathan on Tuesday, January 2. Porter Jonathan D. also sold $21,150 worth of athenahealth, Inc. (NASDAQ:ATHN) shares. Armbrester Bradford Kyle also sold $309,995 worth of athenahealth, Inc. (NASDAQ:ATHN) shares. Shares for $507,744 were bought by IMMELT JEFFREY R on Tuesday, February 27.

athenahealth, Inc., together with its subsidiaries, provides network medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. The company has market cap of $5.70 billion. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for electronic health record management to help manage patientÂ’s clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and well-known provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. It has a 108.55 P/E ratio. The firm also provides athenahealth Population Health, a cloud population health service; and Epocrates service that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research.

Among 29 analysts covering athenaHealth (NASDAQ:ATHN), 11 have Buy rating, 1 Sell and 17 Hold. Therefore 38% are positive. athenaHealth had 88 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of athenahealth, Inc. (NASDAQ:ATHN) has “Buy” rating given on Friday, February 2 by Piper Jaffray. Topeka Capital Markets maintained it with “Hold” rating and $169 target in Monday, December 14 report. On Monday, October 23 the stock rating was maintained by Canaccord Genuity with “Hold”. The stock has “Buy” rating by Oppenheimer on Thursday, July 20. Leerink Swann maintained the shares of ATHN in report on Monday, July 24 with “Hold” rating. Cantor Fitzgerald maintained athenahealth, Inc. (NASDAQ:ATHN) on Friday, October 27 with “Hold” rating. Raymond James upgraded athenahealth, Inc. (NASDAQ:ATHN) on Friday, October 23 to “Outperform” rating. The rating was maintained by Stifel Nicolaus with “Hold” on Thursday, July 20. Robert W. Baird maintained it with “Buy” rating and $155.0 target in Friday, October 20 report. As per Friday, December 16, the company rating was maintained by Dougherty & Company.

New Relic, Inc., a software-as-a-service company, provides digital intelligence products worldwide. The company has market cap of $4.05 billion. The companyÂ’s cloud platform and suite of products include New Relic Digital Intelligence Platform, which enables organizations to collect, store, and analyze data. It currently has negative earnings. It provides New Relic Application Performance Management that offers visibility into the performance and usage of server applications, such as data pertaining to response time, transaction throughput, error rates, transactions, and user satisfaction; New Relic Mobile, which provides code-level visibility into the performance of mobile applications running on the iOS and Android mobile operating systems; and New Relic Browser, a product that monitors the page view experiences of actual end-users for desktop and mobile browser applications.

The stock decreased 2.47% or $1.85 during the last trading session, reaching $73.13. About 924,295 shares traded or 81.62% up from the average. New Relic, Inc. (NYSE:NEWR) has risen 104.05% since April 14, 2017 and is uptrending. It has outperformed by 92.50% the S&P500.

athenahealth, Inc. (NASDAQ:ATHN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>